-+ 0.00%
-+ 0.00%
-+ 0.00%

DiaMedica Therapeutics FY 2024 GAAP EPS $(0.60) Misses $(0.59) Estimate

Benzinga·03/17/2025 20:31:02
Listen to the news
DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0.59) by 1.69 percent.